NPM1 and acute myeloid leukemia: Moreover, we observed that NPM1-mutated AML cases with high VCAN gene expression were associated with a short survival time compared to low VCAN expression cohort, whereas there was no statistical difference (median, 15.17 vs 16.20 months; p = 0.4567, Figure 6B).